secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hims & Hers Health, Inc. (HIMS)
CIK:        0001773751
Form:       8-K
Filed at:   2023-11-06T23:59:59+00:00
Accession:  0001773751-23-000276
Event type: earnings
Sentiment:  positive
Materiality: 0.78
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hims & Hers Q3 revenue $226.7M (+57% YoY), adjusted EBITDA $12.3M; raises FY outlook
--------------------------------------------------------------------------------

- Revenue of $226.7M for Q3 2023, up 57% YoY from $144.8M; net loss narrowed to $7.6M from $18.8M.
- Adjusted EBITDA turned positive at $12.3M vs. ($6.1M) in prior year; gross margin improved to 83% from 79%.
- Subscribers reached 1.4M, up 56% YoY; monthly online revenue per subscriber $54 vs. $56.
- Raised full year 2023 revenue guidance to $868M-$873M and Adjusted EBITDA to $43M-$46M.
- Over 80% of orders fulfilled via affiliated facilities; AI-based MedMatch service introduced to aid personalized care.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1773751/000177375123000276/0001773751-23-000276-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1773751/000177375123000276/hims-20231106.htm
  HTML page:      https://secwatch.observer/filing/0001773751-23-000276

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer